tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

REGN Stock Latest News

3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
Market News3 Best Value Stocks with Over 10% Upside in 2026, According to Analysts 
6h ago
NEM
SNY
Regeneron price target raised to $765 from $745 at RBC Capital
PremiumThe Fly
Regeneron price target raised to $765 from $745 at RBC Capital
1d ago
SNY
REGN
Regeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
PremiumThe Fly
Regeneron, Sanofi announces EMA for CHMP adopted positive opinion for Dupixent
5d ago
SNY
REGN
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
PremiumThe Fly
Regeneron, Sanofi announce FDA approval of Dupixent for AFRS
7d ago
SNY
REGN
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
PremiumMarket News
Here is a List of Small-Cap Biotech ETFs to Watch for Big Gains in 2026
12d ago
BIB
CRBU
Regeneron announces FDA accepted Priority Review for BLA for garetosmab
PremiumThe FlyRegeneron announces FDA accepted Priority Review for BLA for garetosmab
13d ago
REGN
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, Feb. 15
17d ago
J
W
Regeneron Advances REGN7508 Into Phase 3 To Tackle Cancer-Linked Blood Clots
Premium
Company Announcements
Regeneron Advances REGN7508 Into Phase 3 To Tackle Cancer-Linked Blood Clots
18d ago
REGN
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
PremiumCompany Announcements
Sanofi and Regeneron Advance Itepekimab Bet With Completed Phase 2 Bronchiectasis Trial
19d ago
REGN
Regeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
PremiumCompany Announcements
Regeneron and Sanofi Advance Kevzara Into Polymyalgia Rheumatica, Eyeing New Growth Channel
21d ago
SNY
REGN
Regeneron highlights expanding portfolio, pipeline at AAAI
PremiumThe Fly
Regeneron highlights expanding portfolio, pipeline at AAAI
22d ago
SNY
REGN
Regeneron price target raised to $975 from $865 at Guggenheim
PremiumThe Fly
Regeneron price target raised to $975 from $865 at Guggenheim
23d ago
REGN
Regeneron Targets Early Myeloma: New Phase 3 Trial Pits Linvoseltamab Against Daratumumab
PremiumCompany AnnouncementsRegeneron Targets Early Myeloma: New Phase 3 Trial Pits Linvoseltamab Against Daratumumab
25d ago
REGN
Regeneron’s REGN9533 Trial Completion Signals Quiet but Important Progress in Clot-Blocking Drugs
Premium
Company Announcements
Regeneron’s REGN9533 Trial Completion Signals Quiet but Important Progress in Clot-Blocking Drugs
25d ago
REGN
Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
Premium
Company Announcements
Regeneron’s Expanding AI Use Raises Data Privacy, Regulatory and Market Risks
27d ago
REGN
Regeneron Broadens Women’s Health Pipeline With New Phase 2 FHA Trial
PremiumCompany Announcements
Regeneron Broadens Women’s Health Pipeline With New Phase 2 FHA Trial
27d ago
REGN
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
PremiumThe Fly
Regeneron price target raised to $800 from $740 at Cantor Fitzgerald
30d ago
REGN
Regeneron price target raised to $742 from $630 at Baird
PremiumThe Fly
Regeneron price target raised to $742 from $630 at Baird
30d ago
REGN
Regeneron price target raised to $865 from $750 at Oppenheimer
PremiumThe Fly
Regeneron price target raised to $865 from $750 at Oppenheimer
30d ago
REGN
Regeneron announces upcoming presentations at Angiogenesis annual meeting
PremiumThe FlyRegeneron announces upcoming presentations at Angiogenesis annual meeting
30d ago
REGN
Regeneron price target raised to $950 from $850 at JPMorgan
Premium
The Fly
Regeneron price target raised to $950 from $850 at JPMorgan
30d ago
REGN
Regeneron price target raised to $800 from $745 at Wells Fargo
Premium
The Fly
Regeneron price target raised to $800 from $745 at Wells Fargo
1M ago
REGN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >